Paradigm-changing immunotherapy for advanced NSCLC: the PACIFIC and beyond - 102017

Spotlight
Video

Paradigm-changing immunotherapy for advanced NSCLC: the PACIFIC and beyond

VJOncology has 619 videos Subscribe Here

Loading........
Description: Immunotherapy is an exciting area for lung cancer, with numerous possibilities and game-changing potential. Speaking from the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland, Solange Peters, MD, PhD, of Lausanne University Hospital, Lausanne, France, discusses the future of immunotherapy for non-small cell lung cancer (NSCLC). Prof. Peters highlights the recent Phase III PACIFIC trial (NCT02125461) of durvalumab, which produced outstanding progression-free survival results. She then emphasizes what immunotherapy developments she is most excited about.
Shared By : VJOncology
Posted on : 02/05/18
Added : 3 months ago